Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Mar 23, 2010


Complete Genomics has appointed Mark Sutherland as senior vice president of business development. Among his highest priorities will be working more closely with large pharmaceutical companies and the National Institutes of Health. He will also help the company open satellite genome centers in other countries.

Sutherland comes to Complete Genomics from GenVault, where he held the same position. Prior to that, he was vice president of strategic alliances for the Discovery Systems business unit of GE Healthcare, and before that, vice president of genomics for Amersham Biosciences. Previously, he had various sales and marketing management roles at Molecular Dynamics and Applied Biosystems. Sutherland holds a BS in chemistry from Stanford University.

Shankar Balasubramanian has been named Innovator of the Year by the UK's Biotechnology and Biological Sciences Research Council, in recognition of his work on the sequencing technology that was later commercialized by Solexa (now part of Illumina). He received a £10,000 ($15,000) award. Balasubramanian is a professor at the University of Cambridge and a co-founder of Solexa.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.